Ruth Veach
Last active: 4/25/2016

  1. Nuclear transport modulation reduces hypercholesterolemia, atherosclerosis, and fatty liver. Liu Y, Major AS, Zienkiewicz J, Gabriel CL, Veach RA, Moore DJ, Collins RD, Hawiger J (2013) J Am Heart Assoc 2(2): e000093
    › Primary publication · 23563994 (PubMed) · PMC3647260 (PubMed Central)
  2. Lethality in a murine model of pulmonary anthrax is reduced by combining nuclear transport modifier with antimicrobial therapy. Veach RA, Zienkiewicz J, Collins RD, Hawiger J (2012) PLoS One 7(1): e30527
    › Primary publication · 22291977 (PubMed) · PMC3266913 (PubMed Central)
  3. Cutting edge: the "death" adaptor CRADD/RAIDD targets BCL10 and suppresses agonist-induced cytokine expression in T lymphocytes. Lin Q, Liu Y, Moore DJ, Elizer SK, Veach RA, Hawiger J, Ruley HE (2012) J Immunol 188(6): 2493-7
    › Primary publication · 22323537 (PubMed) · PMC3294148 (PubMed Central)
  4. In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes. Moore DJ, Zienkiewicz J, Kendall PL, Liu D, Liu X, Veach RA, Collins RD, Hawiger J (2010) PLoS One 5(10): e13235
    › Primary publication · 20949090 (PubMed) · PMC2950856 (PubMed Central)
  5. Suppression of Staphylococcal Enterotoxin B-induced Toxicity by a Nuclear Import Inhibitor. Liu D, Liu XY, Robinson D, Burnett C, Jackson C, Seele L, Veach RA, Downs S, Collins RD, Ballard DW, Hawiger J (2004) J Biol Chem 279(18): 19239-46
    › Primary publication · 14732709 (PubMed)
  6. Receptor/transporter-independent targeting of functional peptides across the plasma membrane. Veach RA, Liu D, Yao S, Chen Y, Liu XY, Downs S, Hawiger J (2004) J Biol Chem 279(12): 11425-31
    › Primary publication · 14699109 (PubMed)
  7. Peptide-directed suppression of a pro-inflammatory cytokine response. Liu XY, Robinson D, Veach RA, Liu D, Timmons S, Collins RD, Hawiger J (2000) J Biol Chem 275(22): 16774-8
    › Primary publication · 10751381 (PubMed)
  8. IkappaB kinase complex is an intracellular target for endotoxic lipopolysaccharide in human monocytic cells. Hawiger J, Veach RA, Liu XY, Timmons S, Ballard DW (1999) Blood 94(5): 1711-6
    › Primary publication · 10477696 (PubMed)
  9. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. Lin YZ, Yao SY, Veach RA, Torgerson TR, Hawiger J (1995) J Biol Chem 270(24): 14255-8
    › Primary publication · 7782278 (PubMed)
  10. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells. Read MA, Cordle SR, Veach RA, Carlisle CD, Hawiger J (1993) Proc Natl Acad Sci U S A 90(21): 9887-91
    › Primary publication · 7694295 (PubMed) · PMC47677 (PubMed Central)